Physician profile
Joyce Sumpio Smith
NPI 1508985904
$1,598.93
in general payments reported to CMS, 2019-2025
11 companies · $529 in 2025
The $529 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $216 · 2022: $79.73 · 2023: $252 · 2024: $522 · 2025: $529.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,303.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $807.00 | 2023-2025 | |
| Amgen INC. | $246.56 | 2021-2024 | Otezla |
| Pulmonx Corporation | $160.50 | 2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Galderma Laboratories, L.P. | $122.54 | 2022-2025 | Aklief |
| Biofrontera INC. | $71.36 | 2022-2025 | Xepi, Bf-Rhodoled, Ameluz |
| Novartis Pharmaceuticals Corporation | $71.23 | 2021-2023 | |
| Pfizer INC. | $33.46 | 2021-2023 | |
| Allergan, INC. | $28.30 | 2021 | |
| Merz North America, INC. | $26.08 | 2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $17.07 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.83 | 2025 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joyce Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.